Engineered microRNA therapeutics
Targeting of microRNAs that are overexpressed or replacement of microRNAs whose expression is lost are two distinct and novel approaches to treat disease(s) driven by microRNA dysregulation. This can be achieved by chemical modification of either a single stranded oligonucleotide called an anti-miR or a double stranded nucleic acid molecule termed a microRNA mimic.